- Entry
- $7.80
- Now
- $5.98 -23.3%
- Target
- —
- Score
- —
New Nasdaq listing that almost nobody over here has looked at yet. It only started trading on the Nasdaq Global Select Market on 20 July 2026, so it has basically zero US coverage despite being profitable for nine straight years, and despite Sean Parker (Napster, Facebook) and Michael Polansky (Parker Institute, Lady Gaga's partner) having backed it for over 15 years. Short version: $226m enterprise value for a business that did $26m of net profit last year at a 34% …
— ORIGINAL POST ·
CUVL (Clinuvel) - profitable peptide biotech, $226m EV, Phase 3 readout in less than 100 days. Cashed up, no debt.
· r/pennystocks
· Aug 23, 2026